T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells

Clin Exp Allergy. 2014 Jul;44(7):953-64. doi: 10.1111/cea.12330.

Abstract

Background: Inhaled peptide challenge has been shown to induce T cell-mediated, isolated late asthmatic reaction (LAR), characterized by recruitment of CD4(+) T cells and increased levels of thymus and activation-regulated chemokine (TARC; CCL17). Epithelial-derived thymic stromal lymphopoietin (TSLP) has been shown to modulate dendritic cell function to promote TH 2 responses via CCL17 production.

Objectives: To elucidate the mechanisms involved in allergen-specific T cell-induced LAR and recruitment of CD4(+) T cells by examining the effects of T cell-derived factors on the induction of TSLP in primary bronchial epithelial cells (PBEC).

Methods: PBEC grown at air-liquid interface from healthy individuals and patients with asthma were stimulated with double-stranded RNA (dsRNA) or supernatants from activated allergen-specific T cells. TSLP was measured in PBEC culture supernatants. Neutralizing antibodies and signalling inhibitors were used to examine the mechanisms responsible for the induction of epithelial-derived TSLP. The functional activity of PBEC-derived TSLP was measured using a bioassay involving the induction of CCL17 production from monocyte-derived dendritic cells (moDC).

Results: Both dsRNA and allergen-specific T cells induced enhanced TSLP secretion from asthmatic PBEC compared to healthy PBEC. Activated PBEC culture supernatant induced TSLP-dependent CCL17 production from moDC in a manner related to clinical asthmatic status. IL-1β, IL-6, and CXCL8, rather than TH 2 cytokines (IL-4/5/13), appeared to be the principle mediators of allergen-specific T cell-dependent induction of epithelial-derived TSLP, which was regulated by the MEK, MAPK, and NFκB pathways.

Conclusion and clinical relevance: Our data reveal a novel effect of allergen-specific T cells as a positive regulator of TSLP production by epithelial cells, suggesting T cell-airway epithelium interactions that may lead to maintenance and amplification of allergic inflammation. TSLP is currently a candidate for therapeutic intervention in asthma, but the factors that drive TSLP expression (T cell-derived factors) may be equally relevant in the treatment of allergic inflammation.

Keywords: CCL17; T cells; TSLP; airway epithelial cells; allergens; asthma; dendritic cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Allergens / immunology
  • Animals
  • Asthma / genetics
  • Asthma / immunology
  • Asthma / metabolism
  • Asthma / physiopathology
  • Bronchi / immunology
  • Bronchi / metabolism
  • Cats
  • Cell Differentiation
  • Cells, Cultured
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Dendritic Cells / immunology
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Female
  • Gene Expression
  • Humans
  • Immunoglobulin E / blood
  • Immunoglobulin E / immunology
  • Inflammation Mediators / metabolism
  • Ligands
  • MAP Kinase Signaling System
  • Male
  • Middle Aged
  • NF-kappa B / metabolism
  • Poly I-C / pharmacology
  • Respiratory Mucosa / immunology*
  • Respiratory Mucosa / metabolism
  • Signal Transduction
  • T-Cell Antigen Receptor Specificity / immunology
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocyte Subsets / metabolism
  • Thymic Stromal Lymphopoietin
  • Toll-Like Receptor 3 / metabolism
  • Young Adult

Substances

  • Allergens
  • Cytokines
  • Inflammation Mediators
  • Ligands
  • NF-kappa B
  • Toll-Like Receptor 3
  • Immunoglobulin E
  • Poly I-C
  • Thymic Stromal Lymphopoietin